MEDIFAST (MED)
(Delayed Data from NYSE)
$18.11 USD
+0.21 (1.17%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $18.10 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.11 USD
+0.21 (1.17%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $18.10 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Zacks News
Kimberly-Clark's (KMB) Strategic Growth Pillars & Savings Aid
by Zacks Equity Research
Kimberly-Clark (KMB) is committed to its three key strategic growth pillars. Management is focused on efficiently managing costs amid an inflationary environment.
Lamb Weston (LW) Up More Than 30% in 3 Months: Here's Why
by Zacks Equity Research
Lamb Weston (LW) benefits from efforts to boost production capacity and fuel long-term growth. Recovery in the Foodservice business has been yielding.
Service Corporation (SCI) Stock Gains More Than 10% in 3 Months
by Zacks Equity Research
Service Corporation (SCI) has been gaining on robust revenues in the Funeral segment and a focus on expansion. The company is also committed to boosting shareholders' returns.
General Mills (GIS) Poised on Key Priorities & Pet Segment Sales
by Zacks Equity Research
General Mills (GIS) is benefiting from actions related to reshaping the portfolio. The company's solid Pet segment sales are a key growth driver.
Kellogg (K) Benefits From EMEA Region, High Costs a Worry
by Zacks Equity Research
Kellogg Company (K) has been benefiting from strength in the EMEA region and its robust snacks business, especially Pringles. However, cost headwinds prevail.
3 Reasons Why Growth Investors Shouldn't Overlook Medifast (MED)
by Zacks Equity Research
Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Campbell (CPB) Q3 Earnings Top Estimates, Sales Rise Y/Y
by Zacks Equity Research
Campbell Soup's (CPB) third-quarter fiscal 2022 results reflect higher net sales and earnings on growth across all segments. Management raises its fiscal 2022 sales view.
The Estee Lauder Companies' (EL) Latest Move Aids Travel Retail
by Zacks Equity Research
The Estee Lauder Companies (EL) opens a 300,000 square feet state-of-the-art distribution center in Galgenen dedicated to its global Travel Retail business.
United Natural Foods (UNFI) Q3 Earnings & Sales Top Estimates
by Zacks Equity Research
United Natural Foods' (UNFI) third-quarter fiscal 2022 results reflect higher earnings and sales, with all channels witnessing sales growth. Management updates fiscal 2022 guidance.
The J.M. Smucker (SJM) Q4 Earnings Top Estimates, Sales Rise
by Zacks Equity Research
The J.M. Smucker's (SJM) fourth-quarter fiscal 2022 results reflect higher sales, sustained demand and strength in the company's brands. However, cost inflation persists.
The Estee Lauder Companies' (EL) Skin Care Sales Aids Growth
by Zacks Equity Research
The Estee Lauder Companies' (EL) Skin Care portfolio has been performing well for a while now. It is benefiting from strong presence in emerging markets.
Molson Coors (TAP) Rises 17% YTD: Here's What You Should Know
by Zacks Equity Research
Although rising inflation remains concerning, brand strength, product innovation and revitalization plan bode well for Molson Coors (TAP).
Monster Beverage (MNST) Stock Looks Well-Poised Amid Cost Woes
by Zacks Equity Research
Despite freight issues and elevated aluminum can costs, Monster Beverage's (MNST) continued momentum in the energy drinks category and a robust new product pipeline bode well.
Altria (MO) Benefits From Solid Pricing, High Costs a Worry
by Zacks Equity Research
Altria (MO) has been benefiting from its solid pricing power and efforts toward expanding in the oral tobacco products space, while escalation in certain costs is a concern.
Chewy (CHWY) Posts Q1 Earnings Beat & Higher Revenues Y/Y
by Zacks Equity Research
Chewy's (CHWY) first-quarter fiscal 2022 results reflect gains from its strategic moves and strength in the pet category.
Tyson Foods (TSN) Gains on Protein Demand & Capacity Expansion
by Zacks Equity Research
Tyson Foods (TSN) is focused on higher protein production to cater to the rising demand for protein-packed food. Also, capacity expansion efforts are yielding.
Hormel Foods (HRL) Q2 Earnings Top Estimates on Solid Pricing
by Zacks Equity Research
Hormel Foods' (HRL) second-quarter fiscal 2022 results reflect higher earnings and sales, backed by strength across brands and solid pricing.
Nu Skin (NUS) Looks Troubled on Volatile Currency Movements
by Zacks Equity Research
Nu Skin Enterprises (NUS) has been encountering global uncertainties like rising pandemic-related factors, unfavorable currency rates and geopolitical conflicts.
Philip Morris (PM) Gains on Solid Pricing, High Costs a Worry
by Zacks Equity Research
Philip Morris (PM) has been benefiting from its solid pricing power and efforts toward expanding in the reduced risk products space, while escalation in certain costs has been hurting margins.
High Demand & Online Strength Aid Newell (NWL) Amid Inflation
by Zacks Equity Research
Newell (NWL) looks promising on the back of sturdy demand, product innovation and solid online show despite inflation and supply-chain headwinds.
Conagra Brands (CAG) Troubled by Inflation in Cost of Goods
by Zacks Equity Research
Conagra Brands (CAG) has been encountering cost of goods sold inflation for a while now. Gross inflation is likely to be roughly 16% in fiscal 2022.
Should Value Investors Buy MEDIFAST (MED) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Flowers Foods (FLO) on Track to Boost Shareholder Returns
by Zacks Equity Research
Flowers Foods (FLO) is hiking its dividend by 4.8% to boost shareholder wealth. The company increased its share repurchase authorization by 20 million shares.
General Mills (GIS) to Sell Helper Business, Reshape Portfolio
by Zacks Equity Research
General Mills' (GIS) deal to divest the Helper main meals and Suddenly Salad side dishes businesses goes in tandem with the company's Accelerate strategy.
General Mills (GIS) Gains on Accelerate Strategy & Pet Unit Sales
by Zacks Equity Research
General Mills (GIS) is on track with its three key priorities for fiscal 2022, which align with the Accelerate strategy. Solid Pet segment sales are a key driver.